Medical Affairs Outsourcing Market Size To Hit US$ 4.28 Billion By 2030

The global medical affairs outsourcing market size is expected to hit around USD 4.28 billion by 2030 and progressing a CAGR of 12.2% over the forecast period 2022 to 2030.

 

The on medical affairs outsourcing Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/1113

Scope of the Medical Affairs Outsourcing Market Report

Report Highlights	Details
Market Size	US$ 4.28 billion by 2030
Growth Rate	CAGR of 12.2% From 2022 and 2030
Base Year	2021
Historic Data	2017 to 2021
Forecast Period	2022 to 2030
Segments Covered	By Services, By Industry and Regional
Regional Scope	North America, APAC, Europe, Latin America, MEAN, Rest of the World

A recent report provides crucial insights along with application based and forecast information in the Global Medical affairs outsourcing Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Medical affairs outsourcing market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Medical affairs outsourcing market are included as given below:

Medical affairs outsourcing Market Key Players

• ICON plc
• Wuxi Clinical Development, Inc
• Pharmaceutical Product Development, LLC
• Ashfield Healthcare Communications
• Indegene Inc.
• IQVIA Holdings Inc
• The Medical Affairs Company (TMAC)
• SGS SA
• Syneos Health Inc
• ZEINCRO Group

Market Segments

 By Services

• Medical Monitoring
• Medical Writing & Publishing
• Medical Information
• Medical Science Liaisons
• Others

By Industry

• Medical Devices
• Pharmaceutical
• Biopharmaceutical

By Regional Outlook

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Middle East & Africa
• Latin America

Report Objectives

• To define, describe, and forecast the global medical affairs outsourcing market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the medical affairs outsourcing market

Table of Content

 Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Medical Affairs Outsourcing Market, By Services

7.1. Medical Affairs Outsourcing Market, by Services Type, 2021-2030
7.1.1. Medical Monitoring
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Medical Writing & Publishing
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Medical Information
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Medical Science Liaisons
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Medical Affairs Outsourcing Market, By Industry

8.1. Medical Affairs Outsourcing Market, by Industry, 2021-2030
8.1.1. Medical Devices
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Pharmaceutical
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Biopharmaceutical
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Medical Affairs Outsourcing Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.2. Market Revenue and Forecast, by Industry (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Industry (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Industry (2017-2030)

Chapter 10. Company Profiles

10.1. ICON plc
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Wuxi Clinical Development, Inc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Pharmaceutical Product Development, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Ashfield Healthcare Communications
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Indegene Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IQVIA Holdings Inc
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. The Medical Affairs Company (TMAC)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. SGS SA
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Syneos Health Inc
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. ZEINCRO Group
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com